{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:00:18Z","timestamp":1789999218744,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prevalence of diabetes is on a rising trend worldwide as well as in India. Diabetes control remains suboptimal in India\u2019s noncommunicable diseases (NCD) clinics despite the implementation of the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD). This study assessed glycemic status and determinants among diabetics attending health and wellness center (HWCs)\u2013urban primary health centers (UPHCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Cross-sectional study of 164 type 2 diabetics (\u22656 months duration) consecutively recruited from NCD clinics of two UPHCs in the months of October and November 2025. Glycemic status was determined using hemoglobin A1c (HbA1c) where available, or fasting and postprandial blood glucose values according to the American Diabetes Association criteria. Medication adherence was measured using the Hill\u2013Bone Medication Adherence Scale and blood investigation compliance was measured objectively. Multivariable logistic regression identified determinants of uncontrolled glycemic status, and a sensitivity analysis restricted to participants with HbA1c measurements was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The proportion of diabetics with uncontrolled glycemic status was 59.8% (95% confidence interval [CI]: 51.8\u201367.3). Significant predictors included male gender (adjusted odds ratio [aOR]: 2.59; 95% CI: 1.11\u20136.05;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.027), obesity (aOR: 0.31; 95% CI: 0.13\u20130.74;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008), diabetes duration &gt;5 years (aOR: 4.55; 95% CI: 2.02\u201310.21;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and blood investigation non-compliance (aOR: 8.47; 95% CI: 3.54\u201320.28;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Sensitivity analysis yielded findings consistent with the primary analysis. Major barriers to blood investigation non-compliance were inconvenience, waiting time, and forgetfulness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>High uncontrolled glycemia (59.8%) among NCD clinic attendees underscores implementation gaps. Male gender, long duration, and investigation non-compliance drive poor outcomes. Point-of-care testing and targeted interventions can optimize primary care diabetes management under the NP-NCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijcm.ijcm_1_26","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:02:50Z","timestamp":1789750970000},"page":"879-884","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Status and its Determinants among People Living with Type 2 Diabetes Attending NCD clinics of Health and Wellness Centre\u2013Urban Primary Health Centres of Kalyani, Nadia, West Bengal"],"prefix":"10.4103","volume":"51","author":[{"given":"Jeevanmuktha","family":"Somashekara","sequence":"first","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Ahamed","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debkumar","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Palepu","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Majhi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"R3-20260921","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20260921","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R6-20260921","first-page":"854","article-title":"UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R7-20260921","first-page":"S132","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of care in diabetes\u20142026","volume":"49","year":"2025","journal-title":"Diabetes Care"},{"key":"R8-20260921","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/dom.12626","article-title":"Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin","volume":"18","author":"Khunti","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"R9-20260921","doi-asserted-by":"crossref","first-page":"e27677","DOI":"10.1097\/MD.0000000000027677","article-title":"Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R10-20260921","doi-asserted-by":"crossref","first-page":"e000654","DOI":"10.1136\/bmjdrc-2019-000654","article-title":"Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: The TIGHT study","volume":"7","author":"Borgharkar","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R11-20260921","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: Global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20260921","doi-asserted-by":"crossref","first-page":"748157","DOI":"10.3389\/fpubh.2022.748157","article-title":"Prevalence, awareness, treatment and control of diabetes in India from the countrywide national NCD monitoring survey","volume":"10","author":"Mathur","year":"2022","journal-title":"Front Public Health"},{"key":"R13-20260921","first-page":"e56505","article-title":"Exploring the interplay of socioeconomic and behavioral factors: Unraveling gender disparities in glycemic control among adult type 2 diabetic patients in outpatient care","volume":"16","author":"Mankar","year":"2024","journal-title":"Cureus"},{"key":"R16-20260921","first-page":"e18918","article-title":"Assessment of factors associated with non-compliance to self-management practices in people with type 2 diabetes","volume":"13","author":"Rahmatullah,","year":"2021","journal-title":"Cureus"},{"key":"R17-20260921","doi-asserted-by":"crossref","first-page":"689","DOI":"10.18203\/2319-2003.ijbcp20170838","article-title":"Treatment adherence and factors contributing to non adherence among type 2 diabetes mellitus patients in a tertiary care hospital: A cross sectional study","volume":"6","author":"S","year":"2017","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R19-20260921","first-page":"e69956","article-title":"A comparative evaluation of point-of-care and laboratory HbA1c testing in diabetes care: An Indian perspective","volume":"16","author":"Rathod","year":"2024","journal-title":"Cureus"},{"key":"R20-20260921","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4103\/ijcm.ijcm_432_25","article-title":"Validation of the HemoCue\u00ae HbA1c 501 system for point-of-care HbA1c estimation using venous and capillary blood: A comparative study with HPLC in Eastern India","volume":"51","author":"Ahamed","year":"2026","journal-title":"Indian J Community Med"},{"key":"R21-20260921","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/dia.2015.0007","article-title":"Ethnic-specific criteria for classification of body mass index: A perspective for Asian Indians and American Diabetes Association Position Statement","volume":"17","author":"Misra","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"R22-20260921","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1751-7117.2000.tb00211.x","article-title":"Development and testing of the Hill-Bone compliance to high blood pressure therapy scale","volume":"15","author":"Kim","year":"2000","journal-title":"Prog Cardiovasc Nurs"},{"key":"R23-20260921","doi-asserted-by":"crossref","first-page":"107","DOI":"10.18203\/2319-2003.ijbcp20233901","article-title":"Comparison of medication adherence in patients with type 2 diabetes mellitus: A pre and post study","volume":"13","author":"M","year":"2023","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R24-20260921","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.5530\/ijper.20255148","article-title":"Medication adherence of DPP-4 inhibitors in type 2 diabetic management: A Hill-Bone medication adherence scale analysis","volume":"59","author":"Kaliyan","year":"2025","journal-title":"Indian J Pharm Educ Res"},{"key":"R25-20260921","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"R26-20260921","first-page":"362","article-title":"Gender differences in healthcare utilization of patients with diabetes","volume":"18","author":"Kr\u00e4mer","year":"2012","journal-title":"Am J Manag Care"},{"key":"R27-20260921","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M14-1551","article-title":"The obesity paradox in type 2 diabetes mellitus: Relationship of body mass index to prognosis","volume":"162","author":"Costanzo","year":"2015","journal-title":"Ann Intern Med"},{"key":"R28-20260921","first-page":"25","article-title":"Friendly fat theory \u2013 explaining the paradox of diabetes and obesity","volume":"15","author":"Singla","year":"2019","journal-title":"Eur Endocrinol"},{"key":"R29-20260921","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.18203\/2394-6040.ijcmph20184835","article-title":"A study on non-compliance to treatment in a Chennai based diabetic population","volume":"5","author":"Prithika","year":"2018","journal-title":"Int J Community Med Public Health"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_1_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:02:52Z","timestamp":1789995772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_1_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_1_26","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}